Horizon, Pozen jump after Vimovo deal

Moving sharply higher in early trading are shares of Horizon Pharma (HZNP +28.6%) and Pozen (POZN +13.6%) .

Investors are clearly upbeat on HZNP's move to acquire the U.S. rights to Vimovo.

For more on the deal see here.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs